GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » EV-to-EBITDA

Autobio Diagnostics Co (SHSE:603658) EV-to-EBITDA : 18.52 (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Autobio Diagnostics Co's enterprise value is ¥27,407 Mil. Autobio Diagnostics Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,480 Mil. Therefore, Autobio Diagnostics Co's EV-to-EBITDA for today is 18.52.

The historical rank and industry rank for Autobio Diagnostics Co's EV-to-EBITDA or its related term are showing as below:

SHSE:603658' s EV-to-EBITDA Range Over the Past 10 Years
Min: 18.26   Med: 39.72   Max: 85.33
Current: 18.52

During the past 13 years, the highest EV-to-EBITDA of Autobio Diagnostics Co was 85.33. The lowest was 18.26. And the median was 39.72.

SHSE:603658's EV-to-EBITDA is ranked worse than
58.75% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 15.3 vs SHSE:603658: 18.52

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), Autobio Diagnostics Co's stock price is ¥47.73. Autobio Diagnostics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.240. Therefore, Autobio Diagnostics Co's PE Ratio for today is 21.31.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Autobio Diagnostics Co EV-to-EBITDA Historical Data

The historical data trend for Autobio Diagnostics Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co EV-to-EBITDA Chart

Autobio Diagnostics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.46 55.65 21.60 20.25 17.45

Autobio Diagnostics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.26 23.28 20.89 17.45 22.05

Competitive Comparison of Autobio Diagnostics Co's EV-to-EBITDA

For the Medical Devices subindustry, Autobio Diagnostics Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autobio Diagnostics Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's EV-to-EBITDA falls into.



Autobio Diagnostics Co EV-to-EBITDA Calculation

Autobio Diagnostics Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=27407.340/1479.739
=18.52

Autobio Diagnostics Co's current Enterprise Value is ¥27,407 Mil.
Autobio Diagnostics Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,480 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Autobio Diagnostics Co  (SHSE:603658) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Autobio Diagnostics Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=47.73/2.240
=21.31

Autobio Diagnostics Co's share price for today is ¥47.73.
Autobio Diagnostics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.240.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Autobio Diagnostics Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Autobio Diagnostics Co (SHSE:603658) Business Description

Traded in Other Exchanges
N/A
Address
No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.
Executives
Miao Yong Jun Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines